Company / Profit Margin
AXIM BIOTECHNOLOGIES, INC. Profit Margin History
FY2011-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-20395.0%
FY2023
5-year range
-70343.1% / -3453.1%
FY2019-FY2023
Trend
+71.0%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin has fluctuated over the past 9 years, ranging from -70343.1% in FY2022 to -27.9% in FY2011.
Based on SEC 10-K filings.
-20395.0% in FY2023 with a 10-year CAGR of -20276.0%.
Declined from -3453.1% to -20395.0% over the past 5 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -16941.9pp
- 10-Year Change
- -20276.0pp
Key checks
Key Insights
- In FY2023, profit margin increased 71.0% year-over-year.
- Peak profit margin was recorded in FY2011.
- Lowest profit margin in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | -20395.0% | +71.0% |
| FY2022 | -70343.1% | -1937.1% |
| FY2018 | -3453.1% | +60.6% |
| FY2017 | -8761.7% | +29.0% |
| FY2016 | -12346.0% | +39.9% |
| FY2015 | -20539.2% | -17165.7% |
| FY2013 | -119.0% | -245.9% |
| FY2012 | -34.4% | -23.1% |
| FY2011 | -27.9% | - |
As of FY2023 · SEC 10-K · Updated Jun 29, 2026